PATENT CLAIM ANALYSIS

Application Number: 15923135
Application Type: Utility
Filing Date: 2018-03
Publication Date: 2019-02
Patent Classification: ["514", "182000"]

Abstract:
Described are solid pharmaceutical compositions of fusidic acid, and pharmaceutically acceptable salts thereof, dosage units of the pharmaceutical compositions, and packages for pharmaceutical compositions of fusidic acid, and pharmaceutically acceptable salts thereof, which increase stability against the degradation of the fusidic acid, and pharmaceutically acceptable salts thereof. Also described are uses of the pharmaceutical compositions and dosage units in treating diseases.

Claim (Index 65):
The dosage unit of  claim 63  wherein (a) is present at about 10% to about 90% by weight.

Metadata:
- Claim Count in Document: 19.0
- Percentile: 90.0
- Lexical Diversity: 2.22581
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['13666697', '15139138', '12275485', '12487339', '13933788']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.6946788163173259
- 35 USC 102 Novelty (BERT): 0.5121737562291714
- Combined Prediction Score: 0.6764283103085105
- Mean Citation Score: 169.66866199999996
- Max Citation Score: 174.33884
- Similarity Product: 98.87046374552014

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test